You are here

Home

Clinical Trials: Vascular Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Friday, October 8, 2021 - 12:00
Effectiveness of the Autologous Adipose Tissue Harvested With SEFFICARE Method for Treatment of DFU Minor Amputation
Conditions:   Diabetic Foot;   Diabetic Foot Ulcer;   Amputation
Intervention:   Device: SEFFICARE
Sponsors:   Azienda Ospedaliero-Universitaria di Modena;   University of Modena and Reggio Emilia
Not yet recruiting
Posted: Tuesday, September 14, 2021 - 12:00
MSCs for Prevention of MI-induced HF
Conditions:   Myocardial Infarction, Acute;   Myocardial Infarction First;   Myocardial Infarction, Anterior Wall;   Cardiac Remodeling, Ventricular;   STEMI;   Regenerative Medicine;   Heart Failure
Interventions:   Biological: Umbilical Cord-Derived Wharton's Jelly Mesenchymal Stem Cells (WJ-MSCs);   Other: Conventional Treatment
Sponsors:   Shiraz University of Medical Sciences;   National Institute of Medical Research Development (NIMAD), Iran;   Cell Tech Pharmed Company, Iran
Recruiting
Posted: Tuesday, August 17, 2021 - 12:00
Combination of Conditioned Medium and Umbilical Cord-Mesenchymal Stem Cells Therapy for Sub-Acute Stroke Infarct
Condition:   Ischemic Stroke
Interventions:   Biological: Conditioned Medium;   Biological: Umbilical Cord Mesenchymal Stem Cells;   Procedure: Neurologic and Neutrophic Drugs
Sponsor:   PT. Prodia Stem Cell Indonesia
Not yet recruiting
Posted: Monday, August 9, 2021 - 12:00
Effect of Human Umbilical Cord-derived Mesenchymal Stem Cells on Non-cardiac Surgery-induced Lung Injury
Conditions:   Ischemic Heart Disease;   Lung Injury;   Non-cardiac Surgery
Interventions:   Biological: human umbilical cord-derived mesenchymal stem cells;   Other: saline
Sponsor:   Shanghai East Hospital
Recruiting
Posted: Wednesday, July 21, 2021 - 12:00
Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)
Condition:   Skin Ulcer Venous Stasis Chronic
Interventions:   Biological: allo-APZ2-CVU;   Drug: Placebo
Sponsors:   RHEACELL GmbH & Co. KG;   FGK Clinical Research GmbH;   Ticeba GmbH
Not yet recruiting
Posted: Thursday, July 8, 2021 - 12:00
Clinical Plan of Ischemic Stroke
Condition:   Stroke
Intervention:   Biological: it-hMSC
Sponsor:   Peking University Third Hospital
Recruiting
Posted: Friday, June 25, 2021 - 12:00
Treatment of Heart Failure Using Human Umbilical Cord Mesenchymal Stem Cells(hUC-MSC)
Conditions:   Myocardial Ischemia;   Ventricular Dysfunction, Left
Intervention:   Biological: Allogeneic Human Umbilical Cord Mesenchymal Stem Cells
Sponsor:   Shanghai East Hospital
Recruiting
Posted: Thursday, May 27, 2021 - 12:00
PLIN1 Variants in Precocious ACS (SCAPLIN)
Condition:   Acute Coronary Syndrome
Intervention:   Genetic: PLIN1 gene sequencing
Sponsor:   Assistance Publique Hopitaux De Marseille
Not yet recruiting
Posted: Tuesday, May 11, 2021 - 12:00
Liraglutide and Peripheral Artery Disease
Conditions:   Type 2 Diabetes;   Peripheral Arterial Disease
Interventions:   Drug: Liraglutide;   Other: Control
Sponsor:   University of Campania "Luigi Vanvitelli"
Recruiting
Posted: Thursday, May 6, 2021 - 12:00
Potential Use of Autologous and Allogeneic Mesenchymal Stem Cells in Patients With Multiple System Atrophy
Conditions:   Multiple System Atrophy;   Parkinsonism;   Multiple System Atrophy, Parkinson Variant
Interventions:   Biological: Autologous Adipose Mesenchymal Stem Cell Implantation;   Biological: Allogeneic Umbilical Cord Mesenchymal Stem Cell Implantation;   Biological: Allogeneic Umbilical Cord Mesenchymal Stem Cell and Adipose Secretome Implantation
Sponsor:   Indonesia University
Recruiting

Pages